The Vermont Statutes Online
Title 18: Health
Chapter 086: THERAPEUTIC USE OF CANNABIS
- Subchapter 001: RESEARCH PROGRAM
-
§ 4471. Cannabis Therapeutic Research Program; establishment; participation
[Section 4471 repealed effective March 1, 2022]
- Subchapter 002: CANNABIS FOR MEDICAL SYMPTOM USE BY PERSONS WITH SEVERE ILLNESS
-
§ 4472. Definitions
[Section 4472 repealed effective March 1, 2022]
-
§ 4473. Registered patients; qualification standards and procedures
[Section 4473 repealed effective March 1, 2022]
-
§ 4474. Registered caregivers; qualification standards and procedures
[Section 4474 repealed effective March 1, 2022]
-
§ 4474a. Registration; fees
[Section 4474a repealed effective March 1, 2022]
-
§ 4474b. Exemption from criminal and civil penalties; seizure of property
[Section 4474b repealed effective March 1, 2022]
-
§ 4474c. Prohibitions, restrictions, and limitations regarding the use of cannabis for symptom relief
[Section 4474c repealed effective March 1, 2022]
-
§ 4474d. Law enforcement verification of information; rulemaking
[Section 4474d repealed effective March 1, 2022]
-
§ 4474e. Dispensaries; conditions of operation
[Section 4474e repealed effective March 1, 2022]
-
§ 4474f. Dispensary application, approval, and registration
[Section 4474f repealed effective March 1, 2022]
-
§ 4474g. Dispensary Registry identification card; criminal background check
[Section 4474g repealed effective March 1, 2022]
-
§ 4474h. Patient designation of dispensary
[Section 4474h repealed effective March 1, 2022]
-
§ 4474i. Confidentiality of information regarding dispensaries and registered patients
[Section 4474i repealed effective March 1, 2022]
-
§ 4474j. Annual report
[Section 4474j repealed effective March 1, 2022]
-
§ 4474k. Fees; disposition
[Section 4474k repealed effective March 1, 2022]
-
§ 4474l. Regulation by municipalities
[Section 4474l repealed effective March 1, 2022]
-
§ 4474m. Department of Public Safety; provision of educational and safety information
[Section 4474m repealed effective March 1, 2022]
-
§ 4474n. Use of U.S. Food and Drug Administration-approved drugs containing one or more cannabinoids
[Section 4474n repealed effective March 1, 2022]